Reuters exclusively reports Lilly hit by staff accusations, FDA scrutiny at COVID drug factories
Reuters exclusively reported that Eli Lilly & Co employees have accused a factory executive of altering documents required by government […] The post Reuters exclusively reports Lilly hit by staff accusations, FDA scrutiny at COVID drug factories appeared first on Reuters News Agency.
admin
0
50
Reuters exclusively reported that Eli Lilly & Co employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmaker’s COVID-19 treatment. An internal complaint asserts that an official at the company rewrote findings by technical experts to make the conclusions appear more favorable to the company.
The post Reuters exclusively reports Lilly hit by staff accusations, FDA scrutiny at COVID drug factories appeared first on Reuters News Agency.
